MedRhythms, Inc.

MedRhythms is a pioneering biotechnology startup, founded in 2013, with a vision to transform brain health and mobility for individuals worldwide. Their slogan, "Creating a world where everyone with neurologic injuries and diseases has access to the highest quality care," encapsulates their mission. The company is focused on developing advanced neurotherapeutics that harness the synergy of music and technology to revolutionize treatment outcomes. Their patented technology platform integrates sensors, software, and music, utilizing cutting-edge neuroscience to target neural circuitry. This approach is designed to enhance walking, mobility, and related functional abilities in patients with neurological conditions such as stroke, multiple sclerosis, and Parkinson’s disease. Their recent $19.78M Venture Round investment in December 2023 is a testament to their potential to drive innovation in neurology and digital therapeutics. With a clear focus on leveraging technology and music for healthcare, MedRhythms aims to lead the way in redefining treatment possibilities for neurological disorders. For more information, visit their website at https://medrhythms.com/.